Revolade 50 mg (Eltrombopag Olamine)
Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd
Medicine composition: Eltrombopag Olamine
Revolade 50Mg Tablet belongs to a class of drugs called thrombopoietin (TPO) receptor agonists, and is used to treat patients who have low platelet counts as a result of chronic immune thrombocytopenia or chronic hepatitis C virus infection. Revolade 50Mg Tablet is also used in combination with other drugs to treat conditions such as severe aplastic anemia. Generally, this medicine is administered to those patients who have not responded very well to other medicines, or surgery.
Revolade 50Mg Tablet is administered in the form of oral tablets, or via suspension, both of which are taken by the mouth, according to the dosage prescribed by the doctor.
- Longer shelf life
- Precise formulation
- Effective results